{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:38:24Z","timestamp":1787924304318,"version":"build-2784847793"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cbi.2020.109061","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T06:54:20Z","timestamp":1584428060000},"page":"109061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["An alternative pathway for cellular protection in BRAF inhibitor resistance in aggressive melanoma type skin cancer"],"prefix":"10.1016","volume":"323","author":[{"given":"Xiang-Lin","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Zhi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2020.109061_bib1","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/515S110a","article-title":"The cancer that rises with the Sun","volume":"515","author":"Holmes","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2020.109061_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/bjd.15510","article-title":"The global burden of melanoma: results from the Global Burden of Disease Study 2015","volume":"177","author":"Karimkhani","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cbi.2020.109061_bib3","article-title":"Age-specific incidence of melanoma in the United States","author":"Paulson","year":"2019","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.cbi.2020.109061_bib4","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Canc. Biol. Ther."},{"key":"10.1016\/j.cbi.2020.109061_bib5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature05659","article-title":"Scratching the surface of skin development","volume":"445","author":"Fuchs","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2020.109061_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.det.2005.08.001","article-title":"An overview of ultraviolet radiation, sunscreens, and photo-induced dermatoses","volume":"24","author":"Lowe","year":"2006","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.cbi.2020.109061_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R","article-title":"Melanoma and sun exposure: an overview of published studies","volume":"73","author":"Elwood","year":"1997","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.cbi.2020.109061_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-19683-6_1","article-title":"Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system","volume":"212","author":"Slominski","year":"2012","journal-title":"Adv. Anat. Embryol. Cell Biol."},{"key":"10.1016\/j.cbi.2020.109061_bib9","first-page":"457","article-title":"Neuroendocrinology of the skin","volume":"21","author":"Slominski","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cbi.2020.109061_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/occmed\/kqn170","article-title":"Solar ultraviolet radiation and skin cancer","volume":"59","author":"Young","year":"2009","journal-title":"Occupational medicine (Oxford, England)"},{"key":"10.1016\/j.cbi.2020.109061_bib11","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.3390\/ijms140612222","article-title":"UV radiation and the skin","volume":"14","author":"D'Orazio","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2020.109061_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.taap.2006.12.006","article-title":"p53 and the pathogenesis of skin cancer","volume":"224","author":"Benjamin","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2020.109061_bib13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2133.2011.10507.x","article-title":"Roles of the immune system in skin cancer","volume":"165","author":"Rangwala","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cbi.2020.109061_bib14","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1038\/jid.2008.140","article-title":"IL-12 deficiency exacerbates inflammatory responses in UV-irradiated skin and skin tumors","volume":"128","author":"Meeran","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cbi.2020.109061_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fgene.2016.00095","article-title":"Melanocortin 1 receptor: structure, function, and regulation","volume":"7","author":"Wolf Horrell","year":"2016","journal-title":"Front. Genet."},{"key":"10.1016\/j.cbi.2020.109061_bib16","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1242\/dev.127.24.5379","article-title":"Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF","volume":"127","author":"Hou","year":"2000","journal-title":"Development (Cambridge, England)"},{"key":"10.1016\/j.cbi.2020.109061_bib17","doi-asserted-by":"crossref","DOI":"10.1615\/JEnvironPatholToxicolOncol.2018028386","article-title":"Mitogen-activated protein kinase (MAPK): new insights in breast cancer","volume":"38","author":"Lu","year":"2019","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.cbi.2020.109061_bib18","first-page":"950","article-title":"Recent updates on daidzein against oxidative stress and cancer","volume":"18","author":"Rawat","year":"2019","journal-title":"EXCLI journal"},{"key":"10.1016\/j.cbi.2020.109061_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2230.2006.02128.x","article-title":"Proopiomelanocortin (POMC): the cutaneous roles of its melanocortin products and receptors","volume":"31","author":"Millington","year":"2006","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.cbi.2020.109061_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1590\/S0365-05962013000100009","article-title":"Mechanisms regulating melanogenesis","volume":"88","author":"Videira","year":"2013","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.cbi.2020.109061_bib21","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1073\/pnas.0806753106","article-title":"Microarray analysis sheds light on the dedifferentiating role of agouti signal protein in murine melanocytes via the Mc1r","volume":"106","author":"Le Pape","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cbi.2020.109061_bib22","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1038\/sj.onc.1210407","article-title":"Protein regulation of MAPK networks","volume":"26","author":"Goldsmith","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2020.109061_bib23","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1093\/emboj\/19.12.2900","article-title":"Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes","volume":"19","author":"Busca","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2020.109061_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1074\/jbc.M507595200","article-title":"The guanine nucleotide exchange factor CNrasGEF regulates melanogenesis and cell survival in melanoma cells","volume":"281","author":"Amsen","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.109061_bib25","doi-asserted-by":"crossref","first-page":"25568","DOI":"10.1074\/jbc.M101277200","article-title":"A CalDAG-GEFI\/Rap1\/B-Raf cassette couples M(1) muscarinic acetylcholine receptors to the activation of ERK1\/2","volume":"276","author":"Guo","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2020.109061_bib26","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2011.41.2452","article-title":"BRAF\/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma","volume":"30","author":"Colombino","year":"2012","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.cbi.2020.109061_bib27","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2020.109061_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2020.109061_bib29","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1038\/onc.2012.453","article-title":"NRAS mutant melanoma: biological behavior and future strategies for therapeutic management","volume":"32","author":"Fedorenko","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2020.109061_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrclinonc.2011.69","article-title":"BRAF targeted therapy changes the treatment paradigm in melanoma","volume":"8","author":"Ribas","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cbi.2020.109061_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2407-14-13","article-title":"Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations","volume":"14","author":"Ihle","year":"2014","journal-title":"BMC Canc."},{"key":"10.1016\/j.cbi.2020.109061_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsdottir","year":"2013","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.cbi.2020.109061_bib33","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","article-title":"Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma","volume":"29","author":"Long","year":"2011","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.cbi.2020.109061_bib34","series-title":"Preparation and Thermal Behaviour of Polyester Composite Filled with TiO2","author":"Saluja","year":"2017"},{"key":"10.1016\/j.cbi.2020.109061_bib35","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevEukaryotGeneExpr.2019027836","article-title":"Current update on preclinical and clinical studies of resveratrol, a naturally occurring phenolic compound","volume":"vol. 29","author":"Samuel","year":"2019","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.cbi.2020.109061_bib36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAT.0b013e3283532565","article-title":"Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region","volume":"44","author":"Amanuel","year":"2012","journal-title":"Pathology"},{"key":"10.1016\/j.cbi.2020.109061_bib37","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2020.109061_bib38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2020.109061_bib39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.23736\/S0031-0808.18.03398-0","article-title":"Current updates on biological and pharmacological activities of doxycycline","volume":"60","author":"Devi","year":"2018","journal-title":"Panminerva Med."},{"key":"10.1016\/j.cbi.2020.109061_bib40","first-page":"28","article-title":"Role of the tristetraprolin (zinc finger protein 36 homolog) gene in cancer","author":"Gupta","year":"2018","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.cbi.2020.109061_bib41","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600\u2013mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2020.109061_bib42","first-page":"436","article-title":"Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study, the Lancet","volume":"15","author":"Larkin","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.cbi.2020.109061_bib43","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.ejca.2015.08.022","article-title":"Acquired BRAF inhibitor resistance: a multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms","volume":"51","author":"Johnson","year":"2015","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"key":"10.1016\/j.cbi.2020.109061_bib44","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.2011.36.7680","article-title":"RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors","volume":"30","author":"Oberholzer","year":"2012","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.cbi.2020.109061_bib45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","volume":"366","author":"Su","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2020.109061_bib46","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Hauschild","year":"2012","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.cbi.2020.109061_bib47","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2020.109061_bib48","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0140-6736(15)60898-4","article-title":"Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial","volume":"386","author":"Long","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.cbi.2020.109061_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2020.109061_bib50","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","article-title":"Combined vemurafenib and cobimetinib in BRAF-mutated melanoma","volume":"371","author":"Larkin","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cbi.2020.109061_bib51","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41416-019-0673-5","article-title":"Dual-specificity protein phosphatase DUSP4 regulates response to MEK inhibition in BRAF wild-type melanoma","volume":"122","author":"Gupta","year":"2019","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.cbi.2020.109061_bib52","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10555-007-9079-6","article-title":"Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer","volume":"26","author":"Wu","year":"2007","journal-title":"Cancer metastasis reviews"},{"key":"10.1016\/j.cbi.2020.109061_bib53","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1124\/pr.107.00106","article-title":"Mitogen-activated protein (MAP) kinase\/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer","volume":"60","author":"Boutros","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2020.109061_bib54","article-title":"Regulation of dual-specificity phosphatase (DUSP) ubiquitination and protein stability","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2020.109061_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.23736\/S0031-0808.17.03386-9","article-title":"Tumor suppressor role of miR-503","volume":"60","author":"Gupta","year":"2018","journal-title":"Panminerva Med."},{"key":"10.1016\/j.cbi.2020.109061_bib56","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2019.02.021","article-title":"Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases","volume":"304","author":"Mehta","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2020.109061_bib57","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1158\/0008-5472.CAN-13-1385","article-title":"Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer","volume":"73","author":"Balko","year":"2013","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2020.109061_bib58","first-page":"752","article-title":"Anticonvulsant effect of liraglutide, GLP-1 agonist by averting a change in GABA and brain glutathione level on picrotoxin-induced seizures","volume":"16","author":"Gupta","year":"2017","journal-title":"EXCLI journal"},{"key":"10.1016\/j.cbi.2020.109061_bib59","first-page":"155","article-title":"Role of liraglutide in a major complication of diabetes: a critical review of clinical studies","volume":"8","author":"Gupta","year":"2018","journal-title":"Bull. Pharmaceut. Res."},{"key":"10.1016\/j.cbi.2020.109061_bib60","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrm1743","article-title":"Coordinating ERK\/MAPK signalling through scaffolds and inhibitors","volume":"6","author":"Kolch","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cbi.2020.109061_bib61","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/cns.12137","article-title":"Effect of rosiglitazone, a PPAR\u2010\u03b3 ligand on haloperidol\u2010induced catalepsy","volume":"19","author":"Gupta","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cbi.2020.109061_bib62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/1872211309666151030110015","article-title":"The protective action of the aqueous extract of Auricularia polytricha in paracetamol induced hepatotoxicity in rats","volume":"10","author":"Chellappan","year":"2016","journal-title":"Recent Pat. Drug Deliv. Formulation"},{"key":"10.1016\/j.cbi.2020.109061_bib63","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","article-title":"The MEK\/ERK cascade: from signaling specificity to diverse functions","volume":"1773","author":"Shaul","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2020.109061_bib64","first-page":"397","article-title":"Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals","volume":"12","author":"Ballif","year":"2001","journal-title":"Cell Growth Differ. : the molecular biology journal of the American Association for Cancer Research"},{"key":"10.1016\/j.cbi.2020.109061_bib65","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","article-title":"Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms","volume":"286","author":"Bonni","year":"1999","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.cbi.2020.109061_bib66","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1073\/pnas.97.4.1578","article-title":"Survival function of ERK1\/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases","volume":"97","author":"Deng","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cbi.2020.109061_bib67","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.onc.1202367","article-title":"Constitutive activation of the 41-\/43-kDa mitogen-activated protein kinase signaling pathway in human tumors","volume":"18","author":"Hoshino","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2020.109061_bib68","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/01.CIR.0000081947.00070.07","article-title":"RhoA influences the nuclear localization of extracellular signal-regulated kinases to modulate p21Waf\/Cip1 expression","volume":"108","author":"Zuckerbraun","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2020.109061_bib69","series-title":"Recent Updates on Neuropharmacological Effects of Luteolin","author":"Gupta","year":"2018"},{"key":"10.1016\/j.cbi.2020.109061_bib70","series-title":"Obesity and Diabetes: Pathophysiology of Obesity-Induced Hyperglycemia and Insulin Resistance, Pathophysiology of Obesity-Induced Health Complications","first-page":"81","author":"Gupta","year":"2020"},{"key":"10.1016\/j.cbi.2020.109061_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148095","article-title":"Melanoma expressed-CD70 is regulated by RhoA and MAPK pathways without affecting vemurafenib treatment activity","volume":"11","author":"Pich","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2020.109061_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ncb1833","article-title":"Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis","volume":"11","author":"Medjkane","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cbi.2020.109061_bib73","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2015.07.061","article-title":"Non-genomic and immune evolution of melanoma acquiring MAPKi resistance","volume":"162","author":"Hugo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2020.109061_bib74","doi-asserted-by":"crossref","first-page":"462","DOI":"10.15252\/embj.201592081","article-title":"Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP\/TAZ activation","volume":"35","author":"Kim","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2020.109061_bib75","doi-asserted-by":"crossref","first-page":"110257","DOI":"10.18632\/oncotarget.22628","article-title":"Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells","volume":"8","author":"Fisher","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2020.109061_bib76","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ng.3218","article-title":"The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies","volume":"47","author":"Lin","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cbi.2020.109061_bib77","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1573413712666160926095324","article-title":"A comparative investigation on various platinum nanoparticles decorated carbon supports for oxygen reduction reaction","volume":"13","author":"Narasimulu","year":"2017","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.cbi.2020.109061_bib78","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jep.2012.03.013","article-title":"Sedative, antiepileptic and antipsychotic effects of Viscum album L.(Loranthaceae) in mice and rats","volume":"141","author":"Gupta","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cbi.2020.109061_bib79","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/35070009","article-title":"Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I","volume":"3","author":"Coleman","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cbi.2020.109061_bib80","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11010-014-2064-9","article-title":"Protective effect of pioglitazone, a PPAR\u03b3 agonist against acetaminophen-induced hepatotoxicity in rats","volume":"393","author":"Gupta","year":"2014","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2020.109061_bib81","unstructured":"X. Liu, R. Sharma, A. Mishra, G.K. Chinnaboina, G. Gupta, M. Singh, Role of Aqueous Extract of Wood Ear Mushroom, Auricularia Polytricha in Avoidance of Haloperidol-Induced Catalepsy via Oxidative Stress in Rats."},{"key":"10.1016\/j.cbi.2020.109061_bib82","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/cdd.2010.36","article-title":"Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation","volume":"17","author":"Ehrenschwender","year":"2010","journal-title":"Cell Death Differ."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279720302489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279720302489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:58:35Z","timestamp":1757858315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279720302489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":82,"alternative-id":["S0009279720302489"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109061","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An alternative pathway for cellular protection in BRAF inhibitor resistance in aggressive melanoma type skin cancer","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2020.109061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109061"}}